Bonsity Expands Treatment Options for Patients With Osteoporosis
Osteoporosis is a chronic skeletal condition in which bones gradually become weaker and more susceptible to fractures. The disease is particularly prevalent among aging populations and continues to create substantial healthcare challenges. The U.S. Food and Drug Administration (FDA) approved bonsity, also identified as PF708 or teriparatide injection, for specific individuals with osteoporosis...
0 Комментарии
0 Поделились